Search research articles
Contact Us
Filters
Showing results (41-50 of 270) with videos related to
Page
of 27
Sort By:
European Heart Journal
|
March 4, 2025
Targeted approach for next-generation coronary stents
Simon D Brown, Julie Rodor, Andrew H Baker
Journal of Cell Science
|
September 18, 2002
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Andrew H Baker, Dylan R Edwards, Gillian Murphy
Human Gene Therapy
|
May 20, 2015
Special focus issue on the annual meeting of the British Society for Gene and Cell Therapy
Stuart A Nicklin, Uta Griesenbach, Andrew H Baker
Cardiovascular Research
|
June 26, 2020
Tissue-selective endothelial arousal revealed by vascular endothelial growth factor gene transfer
Emmanouil G Solomonidis, Andrew H Baker, Mairi Brittan
Current Opinion in Lipidology
|
July 30, 2016
Role of noncoding RNA in vascular remodelling
Lin Deng, Angela C Bradshaw, Andrew H Baker
Cardiovascular Research
|
July 31, 2015
Micro(RNA) management of smooth muscle cell phenotype and response to vascular injury
Robert A Mcdonald, Karine Pinel, Andrew H Baker
Cardiovascular Research
|
September 25, 2018
A new "lnc" between non-coding RNA and cardiac regeneration
Marco Meloni, Paul R Riley, Andrew H Baker
Cardiovascular Research
|
May 12, 2023
Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
Julie Rodor, Shiau-Haln Chen, Andrew H Baker
Current Opinion in Molecular Therapeutics
|
September 8, 2006
Gene therapy and coronary artery bypass grafting: current perspectives
Sarah J George, Keith M Channon, Andrew H Baker
Genetic Vaccines and Therapy
|
October 12, 2004
Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector
Lorraine M Work, Paul N Reynolds, Andrew H Baker
Page
of 27
Search research articles
Search
Showing results (41-50 of 270) with videos related to
Sort By:
Page
of 27
European Heart Journal
|
March 4, 2025
Targeted approach for next-generation coronary stents
Simon D Brown, Julie Rodor, Andrew H Baker
Journal of Cell Science
|
September 18, 2002
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Andrew H Baker, Dylan R Edwards, Gillian Murphy
Human Gene Therapy
|
May 20, 2015
Special focus issue on the annual meeting of the British Society for Gene and Cell Therapy
Stuart A Nicklin, Uta Griesenbach, Andrew H Baker
Cardiovascular Research
|
June 26, 2020
Tissue-selective endothelial arousal revealed by vascular endothelial growth factor gene transfer
Emmanouil G Solomonidis, Andrew H Baker, Mairi Brittan
Current Opinion in Lipidology
|
July 30, 2016
Role of noncoding RNA in vascular remodelling
Lin Deng, Angela C Bradshaw, Andrew H Baker
Cardiovascular Research
|
July 31, 2015
Micro(RNA) management of smooth muscle cell phenotype and response to vascular injury
Robert A Mcdonald, Karine Pinel, Andrew H Baker
Cardiovascular Research
|
September 25, 2018
A new "lnc" between non-coding RNA and cardiac regeneration
Marco Meloni, Paul R Riley, Andrew H Baker
Cardiovascular Research
|
May 12, 2023
Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
Julie Rodor, Shiau-Haln Chen, Andrew H Baker
Current Opinion in Molecular Therapeutics
|
September 8, 2006
Gene therapy and coronary artery bypass grafting: current perspectives
Sarah J George, Keith M Channon, Andrew H Baker
Genetic Vaccines and Therapy
|
October 12, 2004
Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector
Lorraine M Work, Paul N Reynolds, Andrew H Baker
Page
of 27